Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2'deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement

Journal of Immunological Methods

Volumn 415, Issue , 2014, Pages 71-79

  Poujol, Fanny ^a   Monneret, Guillaume ^a   Friggeri, Arnaud ^b   Rimmelé, Thomas ^c   Malcus, Christophe ^a   Poitevin Later, Françoise ^a   Pachot, Alexandre ^a   Lepape, Alain ^b   Textoris, Julien ^a,c   Venet, Fabienne ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

EdU; Flow cytometry; Lymphocyte; Proliferation; 3H Thymidine

Indexed keywords

CD3 ANTIGEN; EDOXUDINE; THYMIDINE; 5-ETHYNYL-2'-DEOXYURIDINE; ALLOPHYCOCYANIN; DEOXYURIDINE; FLUORESCENT DYE; MONOCLONAL ANTIBODY; PHYCOCYANIN; PHYTOHEMAGGLUTININ; TRITIUM;

ADOLESCENT; ARTICLE; CELL CONTACT; CELL PROLIFERATION; CHILD; CLINICAL LABORATORY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE TRANSFORMATION TEST; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; SCHOOL CHILD; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; PROCEDURES; REPRODUCIBILITY; SEPTIC SHOCK; TRANSPORT AT THE CELLULAR LEVEL;

ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; CELL PROLIFERATION; DEOXYURIDINE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHYCOCYANIN; PHYTOHEMAGGLUTININS; PRIMARY CELL CULTURE; REPRODUCIBILITY OF RESULTS; SHOCK, SEPTIC; THYMIDINE; TRITIUM;

EID: 84912096168     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.10.006     Document Type: Article

References (18)

1. Bading J.R., Shields A.F. Imaging of cell proliferation: status and prospects. J. Nucl. Med. 2008, 49(Suppl. 2):64S.
2. Barna B.P., Culver D.A., Yen-Lieberman B., Dweik R.A., Thomassen M.J. Clinical application of beryllium lymphocyte proliferation testing. Clin. Diagn. Lab. Immunol. 2003, 10:990.
3. Begum J., Day W., Henderson C., Purewal S., Cerveira J., Summers H., et al. A method for evaluating the use of fluorescent dyes to track proliferation in cell lines by dye dilution. Cytometry 2013, 83:1085.
4. Buck S.B., Bradford J., Gee K.R., Agnew B.J., Clarke S.T., Salic A. Detection of S-phase cell cycle progression using 5-ethynyl-2'-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2'-deoxyuridine antibodies. BioTech. 2008, 44:927.
5. de Vries E. European Society for Immunodeficiencies (ESID) members, patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin. Exp. Immunol. 2012, 167:108. 10.1111/j.1365-2249.2011.04461.x.
6. Dolbeare F., Beisker W., Pallavicini M.G., Vanderlaan M., Gray J.W. Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Cytometry 1985, 6:521.
7. Gonchoroff N.J., Katzmann J.A., Currie R.M., Evans E.L., Houck D.W., Kline B.C., et al. S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment. J. Immunol. Methods 1986, 93:97.
8. Guignant C., Lepape A., Huang X., Kherouf H., Denis L., Poitevin F., et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care 2011, 15:R99.
9. Hammers H.J., Saballus M., Sheikzadeh S., Schlenke P. Introduction of a novel proliferation assay for pharmacological studies allowing the combination of BrdU detection and phenotyping. J. Immunol. Methods 2002, 264:89.
10. Lindegren L.K.Mary Lou Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR 2004, 53:1.
11. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994, 171:131.
12. Marits P., Wikström A.-C., Popadic D., Winqvist O., Thunberg S. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. Clin. Immunol. 2014, 153:332.
13. Ranall M.V., Gabrielli B.G., Gonda T.J. Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening. BioTech. 2010, 48:379.
14. Rew D.A., Wilson G.D. Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. Eur. J. Surg. Oncol. 2000, 26:227.
15. Rothaeusler K., Baumgarth N. Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry. Cytometry 2006, 69A:249.
16. Sun Y., Sun Y., Lin G., Zhang R., Zhang K., Xie J., et al. Multicolor flow cytometry analysis of the proliferations of T-lymphocyte subsets in vitro by EdU incorporation. Cytometry 2012, 81:901.
17. Venet F., Foray A.-P., Villars-Méchin A., Malcus C., Poitevin-Later F., Lepape A., et al. IL-7 restores lymphocyte functions in septic patients. J. Immunol. 2012, 189:5073.
18. Yu Y., Arora A., Min W., Roifman C.M., Grunebaum E. EdU incorporation is an alternative non-radioactive assay to [(3)H]thymidine uptake for in vitro measurement of mice T-cell proliferations. J. Immunol. Methods 2009, 350:29.